Vaccination and Vaccine Effectiveness

Dear Colleagues,

Vaccination is universally recognized as one of the best strategies that have increased duration and quality of life during the last centuries. However, vaccination coverages are often below the recommended levels to reduce the circulation of and extinguish vaccine-preventable diseases. In several countries, vaccination acceptance is low because of misconceptions or doubts about the effectiveness and safety of vaccines. Vaccine hesitancy involves at least 15% of the general population, and even healthcare workers sometimes express doubts on vaccination effectiveness and safety.

This Special Issue will contribute to the enhancement of international literature data on vaccine effectiveness and safety and on strategies that could help reduce vaccine hesitancy and improve vaccination coverage.

Manuscripts reporting on vaccines administered to infants, adolescents, adults, elderly people, at-risk populations (susceptible to comorbidities and presenting personal risk factors), and healthcare workers and on strategies adopted to promote vaccination adherence by these categories are welcomed for this Special Issue.

This Special Issue encourages the submission of original articles, systematic reviews, meta-analyses, short communications, and other types of article that can improve our knowledge on vaccine effectiveness and related topics, such as vaccine safety and strategies to increase vaccination acceptance.

Prof. Alessandra Casuccio
Dr. Vincenzo Restivo
Dr. Claudio Costantino
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.